NLM Logo

P-DOCE protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
P-DOCE protocol
Unique ID
C083922
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C083922
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Doxorubicin
Etoposide
Prednisone
Vincristine
Epirubicin
Frequency
1
Note
chemotherapy regimen consisting of epirubicin, vincristine, cyclophosphamide, etoposide and prednisone; doxorubicin can be substituted for epirubicin at weeks 1,2,7, and 8; used for the treatment of large-cell lymphoma
Source
J Clin Oncol 1993 Nov;11(11):2250-7
Date of Entry
1993/11/29
Revision Date
2000/11/30
P-DOCE protocol Preferred
page delivered in 0.004s